학술논문
The Copenhagen Actinic Keratosis Study (COAKS). A decentralised clinical trial to evaluate tolerability, safety and efficacy of daily field-directed topical treatment with cytosolic phospholipase A 2 inhibitor, AVX001, in participants with actinic keratosis: protocol for a randomised controlled phase I/IIa trial
Document Type
Article
Author
Source
In: BMJ Open . (BMJ Open, 5 October 2022, 12(10))
Subject
Language
English
ISSN
20446055